Normal Saline for Parenteral Use Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast latest study published by Fortune Business Insights. The global ”normal saline for parenteral use market” size is projected to reach USD 3.71 billion by 2026, exhibiting a CAGR of 5.4% during the forecast period. Increasing prevalence of diarrhea worldwide will be a prominent growth driver for this market, shares Fortune Business Insights™ in its report, titled “Global Normal Saline for Parenteral Use Market Size, Share & COVID-19 Impact Analysis, By Type (Plastic Bottles and Glass Bottles), By Application (Intramuscular Injection and Intravenous Injection), and Regional Forecast, 2020-2026”.
According to the World Health Organization (WHO), diarrhea is the second leading cause of death in children under five years of age, killing around 525,000 children under five every year. The WHO estimates that there are approximately 1.7 billion cases of childhood diarrhea each year, globally. Diarrhea lasts for several days and depletes the body’s water and mineral resources, leaving the patient severely dehydrated. The complications can get aggravated in children whose bodies cannot withstand the effects of such diseases. Normal saline for parenteral use is the quickest and the most efficient way of injecting a diarrheal patient’s body with the necessary fluids and prevent imminent death. Saline, which is 0.9% sodium chloride solution, contains the essential ingredients required to reboot a dehydrated body and is thus widely used in healthcare facilities around the world.
Request a Sample Copy of the Research Report:
This report focuses on Normal Saline for Parenteral Use Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
The COVID-19 pandemic has had a seismic effect on several economies across the globe. To curb the pandemic spread, the governments of several countries have ordered complete lockdown of industrial and human activities. This is expected to have a significant impact on the market in 2021. However, proactive steps by the industry leaders to revive the Healthcare industry will bode well for the growth of the market in the near future.
For more information visit :
https://www.fortunebusinessinsights.com/normal-saline-for-parenteral-use-market-104520
The report states that the market value stood at USD 2.88 billion in 2019 and provides the following:
- Worm’s eye-view analysis of the various factors driving and constraining the market;
- Panoramic overview of the current industry outlook and trends;
- Granular examination of all market segments; and
- Comprehensive evaluation of the regional developments and competitive dynamics of the market.
Restraining Factor
Cancelation of Surgeries amid COVID-19 to Negatively Impact the Market
With coronavirus cases continuing their upward spiral across the globe, the provision of surgical services, especially elective ones, has plunged. A 120-country research initiative, led by the University of Birmingham, called the CovidSurg Collaborative estimates that nearly 28.4 million elective surgeries worldwide are likely to get canceled or deferred in 2020. This will mainly be a result of governments redirecting their medical and health resources towards treating COVID-19 patients and preventing hospitals from getting overwhelmed with the escalating number of infections. In the UK, for example, the National Health Service (NHS) issued a directive in April to hospitals that led to the cancelation of over 2.1 million routine surgeries across the country, as the NHS prepared to tackle the impending coronavirus peak. The steep decline in surgeries has led to considerable revenue shortfalls for market companies, impacting the normal saline for parenteral use market growth further. For example, ICU Medical’s gross profit in the third quarter of 2020 was 36% as compared to 39% in 2019.
Quick Buy – Normal Saline for Parenteral Use Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/104520
Regional Insights
Robust Healthcare Facilities to Bolster North America’s Leading Market Position
At USD 1.10 billion, North America dominated the normal saline for parenteral use market share in 2019 and is expected to retain its commanding position throughout the forecast period. This will be mainly because of the strong and well-established healthcare infrastructure in the US and Canada. Manufacturers in the region have also been aggressively expanding their production capacities to cater to the growing demand for saline owing to the increasing number of inpatient hospital admissions.
In Asia Pacific, the primary growth determinants for the market are the rapidly expanding patient population and improving healthcare facilities. Strong support from regulatory authorities in the European Union (EU) will aid market growth in Europe.
Competitive Landscape
Supportive Regulatory Climate for Novel Solutions to Stoke Innovation
Key players in this market are capitalizing on the favorable regulatory climate for normal saline products. Regulatory bodies such as the US Food and Drug Administration (FDA) are giving timely approvals to IV solutions to empower hospitals to efficiently deal with emergency health situations and improve patient outcomes.
Industry Developments:
July 2019: Baxter International received approval from the US FDA for its Insulin Human in 0.9% Sodium Chloride Injection, Myxredlin. The injection is the first and only ready-to-use insulin for IV infusion in health facilities, featuring an extended shelf-life of 30 days at room temperature.
January 2018:B. Braun Medical secured clearance for its 0.9% Sodium Chloride Injection, the Ecoflac™ Plus, from the US FDA. With this intravenous solution, B. Braun has expanded its current line of IV options for the administration of normal saline.
Have Any Query? Ask Our Experts:
List of Key Companies Profiled in the Normal Saline for Parenteral Use Market Report:
- Pharmally International Holding Co., Ltd. ( Shangdong, China)
- Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)
- ICU Medical (Illinois, U.S.)
- Fresenius Kabi AG (Bad Homburg, Germany)
- Kelun Group (Sichuan, China)
- Cisen Pharmaceutical Co., Ltd. (Shangdong, China)
- Double-Crane Pharmaceutical Co., Ltd. (China)
- Braun Melsungen AG (Melsungen, Germany)
- Baxter (Illinois, U.S.)
- SSY Group Limited (Hong Kong)
Table of Content:
1 Normal Saline for Parenteral Use Market Overview
1.1 Normal Saline for Parenteral Use Product Overview
1.2 Normal Saline for Parenteral Use Market Segment by Type
1.3 Global Normal Saline for Parenteral Use Market Size by Type (2015-2027)
1.3.1 Global Normal Saline for Parenteral Use Market Size Overview by Type (2015-2027)
1.3.2 Global Normal Saline for Parenteral Use Historic Market Size Review by Type (2015-2021)
1.3.2.1 Global Normal Saline for Parenteral Use Sales Market Share Breakdown by Type (2015-2027)
1.3.2.2 Global Normal Saline for Parenteral Use Market Share Breakdown by Type (2015-2027)
1.3.2.3 Global Normal Saline for Parenteral Use Average Selling Price (ASP) by Type (2015-2027)
1.3.3 Global Normal Saline for Parenteral Use Market Size Forecast by Type (2021-2027)
1.3.3.1 Global Normal Saline for Parenteral Use Sales Market Share Breakdown by Application (2021-2027)
1.3.3.2 Global Normal Saline for Parenteral Use Revenue Market Share Breakdown by Application (2021-2027)
1.3.3.3 Global Normal Saline for Parenteral Use Average Selling Price (ASP) by Application (2021-2027)
1.4 Key Regions Market Size Segment by Type (2015-2021)
1.4.1 North America Normal Saline for Parenteral Use Sales Breakdown by Type (2015-2027)
1.4.2 Europe Normal Saline for Parenteral Use Sales Breakdown by Type (2015-2027)
1.4.3 Asia-Pacific Normal Saline for Parenteral Use Sales Breakdown by Type (2015-2027)
1.4.4 Latin America Normal Saline for Parenteral Use Sales Breakdown by Type (2015-2027)
1.4.5 Middle East and Africa Normal Saline for Parenteral Use Sales Breakdown by Type (2015-2027)
2 Global Normal Saline for Parenteral Use Market Competition by Company
2.1 Global Top Players by Normal Saline for Parenteral Use Sales (2015-2021)
2.2 Global Top Players by Normal Saline for Parenteral Use Revenue (2015-2021)
2.3 Global Top Players Normal Saline for Parenteral Use Average Selling Price (ASP) (2015-2021)
2.4 Global Top Company Normal Saline for Parenteral Use Manufacturing Base Distribution, Sales Area, Product Type
2.5 Normal Saline for Parenteral Use Market Competitive Situation and Trends
2.5.1 Normal Saline for Parenteral Use Market Growth Rate (2015-2021)
2.5.2 Global 5 and 10 Largest Company by Normal Saline for Parenteral Use Sales and Revenue in 2019
2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Normal Saline for Parenteral Use as of 2019)
2.7 Date of Key Company Enter into Normal Saline for Parenteral Use Market
2.8 Key Company Normal Saline for Parenteral Use Product Offered
2.9 Mergers and Acquisitions, Expansion
3 Global Normal Saline for Parenteral Use Status and Outlook by Region (2015-2027)
3.1 Global Normal Saline for Parenteral Use Market Size and CAGR by Region: 2015 VS 2021 VS 2027
3.2 Global Normal Saline for Parenteral Use Market Size Market Share by Region (2015-2021)
3.2.1 Global Normal Saline for Parenteral Use Sales Market Share by Region (2015-2021)
3.2.2 Global Normal Saline for Parenteral Use Revenue Market Share by Region (2015-2021)
3.2.3 Global Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2015-2021)
3.3 Global Normal Saline for Parenteral Use Market Size Market Share by Region (2021-2027)
3.3.1 Global Normal Saline for Parenteral Use Sales Market Share by Region (2021-2027)
3.3.2 Global Normal Saline for Parenteral Use Revenue Market Share by Region (2021-2027)
3.3.3 Global Normal Saline for Parenteral Use Sales, Revenue, Price and Gross Margin (2021-2027)
3.4 North America Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
3.4.1 North America Normal Saline for Parenteral Use Revenue By Growth (2015-2027)
3.4.2 North America Normal Saline for Parenteral Use Sales By Growth (2015-2027)
3.5 Asia-Pacific Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
3.5.1 Asia-Pacific Normal Saline for Parenteral Use Revenue By Growth (2015-2027)
3.5.2 Asia-Pacific Normal Saline for Parenteral Use Sales By Growth (2015-2027)
3.6 Europe Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
3.6.1 Europe Normal Saline for Parenteral Use Revenue By Growth (2015-2027)
3.6.2 Europe Normal Saline for Parenteral Use Sales By Growth (2015-2027)
3.7 Latin America Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
3.7.1 Latin America Normal Saline for Parenteral Use Revenue By Growth (2015-2027)
3.7.2 Latin America Normal Saline for Parenteral Use Sales By Growth (2015-2027)
3.8 Middle East and Africa Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
3.8.1 Middle East and Africa Normal Saline for Parenteral Use Revenue By Growth (2015-2027)
3.8.2 Middle East and Africa Normal Saline for Parenteral Use Sales By Growth (2015-2027)
4 Global Normal Saline for Parenteral Use by Application
4.1 Normal Saline for Parenteral Use Segment by Application
4.1.1 Residential
4.1.2 Commercial
4.2 Global Normal Saline for Parenteral Use Sales by Application: 2015 VS 2021 VS 2027
4.3 Global Normal Saline for Parenteral Use Historic Sales by Application (2015-2021)
4.4 Global Normal Saline for Parenteral Use Forecasted Sales by Application (2021-2027)
4.5 Key Regions Normal Saline for Parenteral Use Market Size by Application
4.5.1 North America Normal Saline for Parenteral Use by Application
4.5.2 Europe Normal Saline for Parenteral Use by Application
4.5.3 Asia-Pacific Normal Saline for Parenteral Use by Application
4.5.4 Latin America Normal Saline for Parenteral Use by Application
4.5.5 Middle East and Africa Normal Saline for Parenteral Use by Application
5 North America Normal Saline for Parenteral Use Market Size by Country (2015-2027)
5.1 North America Market Size Market Share by Country (2015-2021)
5.1.1 North America Normal Saline for Parenteral Use Sales Market Share by Country (2015-2021)
5.1.2 North America Normal Saline for Parenteral Use Revenue Market Share by Country (2015-2021)
5.2 North America Market Size Market Share by Country (2021-2027)
5.2.1 North America Normal Saline for Parenteral Use Sales Market Share by Country (2021-2027)
5.2.2 North America Normal Saline for Parenteral Use Revenue Market Share by Country (2021-2027)
5.3 North America Market Size By Growth by Country
5.3.1 U.S. Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
5.3.2 Canada Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
6 Europe Normal Saline for Parenteral Use Market Size by Country (2015-2027)
6.1 Europe Market Size Market Share by Country (2015-2021)
6.1.1 Europe Normal Saline for Parenteral Use Sales Market Share by Country (2015-2021)
6.1.2 Europe Normal Saline for Parenteral Use Revenue Market Share by Country (2015-2021)
6.2 Europe Market Size Market Share by Country (2021-2027)
6.2.1 Europe Normal Saline for Parenteral Use Sales Market Share by Country (2021-2027)
6.2.2 Europe Normal Saline for Parenteral Use Revenue Market Share by Country (2021-2027)
6.3 Europe Market Size By Growth by Country
6.3.1 Germany Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
6.3.2 France Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
6.3.3 U.K. Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
6.3.4 Italy Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
6.3.5 Russia Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7 Asia-Pacific Normal Saline for Parenteral Use Market Size by Country (2015-2027)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)
7.1.1 Asia-Pacific Normal Saline for Parenteral Use Sales Market Share by Country (2015-2021)
7.1.2 Asia-Pacific Normal Saline for Parenteral Use Revenue Market Share by Country (2015-2021)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)
7.2.1 Asia-Pacific Normal Saline for Parenteral Use Sales Market Share by Country (2021-2027)
7.2.2 Asia-Pacific Normal Saline for Parenteral Use Revenue Market Share by Country (2021-2027)
7.3 Asia-Pacific Market Size By Growth by Country
7.3.1 China Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.2 Japan Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.3 South Korea Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.4 India Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.5 Australia Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.6 Taiwan Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.7 Indonesia Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.8 Thailand Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.9 Malaysia Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
7.3.10 Philippines Normal Saline for Parenteral Use Market Size By Growth (2015-2027)
Global Normal Saline for Parenteral Use Market Segmentation :
Segments Covered in the Report
By Type
- Plastic Bottles
- Glass Bottles
By Application
- Intramuscular Injection
- Intravenous Injection
By Geography
- North America
- By Type
- By Application
- By Country
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245